Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Staar Surgical Company (NQ: STAA )

44.91 +0.22 (+0.49%)
Streaming Delayed Price Updated: 12:46 PM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Staar Surgical Company

< Previous 1 2 3 4 5 Next >
8 Analysts Have This to Say About Staar Surgical
Via Benzinga
Smartsheet, Kroger, Lantronix And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session. Lantronix, Inc. (NASDAQ: LTRX) shares jumped 26.3% to... 
Via Benzinga
Topics Stocks
Exposures US Equities
Around $8M Bet On STAAR Surgical? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed mostly lower on Thursday, there were a few notable insider trades. 
Via Benzinga
What 9 Analyst Ratings Have To Say About Staar Surgical
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 128 companies set new 52-week lows. 
Via Benzinga
Why STAAR Surgical Stock Dropped Today
The implantable lens specialist posted a mixed quarter and lowered its 2023 outlook. 
Via The Motley Fool
6 Analysts Have This to Say About Staar Surgical
Via Benzinga
3 ‘Strong Buy’ Growth Stocks You Should Be Loading Up On Now
Loading up on these undervalued growth stocks will likely pay off tremendously in the long-run as Wall Street diverts its attention from AI. 
Via InvestorPlace
Why Cummins Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares jumped 75% to $9.60. 
Via Benzinga
What 4 Analyst Ratings Have To Say About Staar Surgical
Via Benzinga
Analyst Ratings for Staar Surgical
Via Benzinga
Recap: Staar Surgical Q1 Earnings
Via Benzinga
STAAR Surgical Stock Tumbles After Q2 Earnings: Here's Why
STAAR Surgical Company's (NASDAQ: STAA) Q2 sales reached $92.3 million, up 14% Y/Y, driven by ICL sales growth of 19% and ICL unit growth of 21%, missing the  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
The Latest Analyst Ratings for Staar Surgical
Via Benzinga
Expert Ratings for Staar Surgical
Via Benzinga
Staar Surgical Earnings Preview
Via Benzinga
Yum! Brands To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday
Needham raised the price target for Extreme Networks, Inc. (NASDAQ: EXTR) from $30 to $35. Needham analyst Alex Henderson maintained a Buy rating. Extreme Networks shares fell 1.7% to $29.70 in... 
Via Benzinga
Qualcomm, PayPal, Etsy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
10 Best Stocks to Buy Now, Stock Market News, and Investing Q&A
Where is the stock market headed and which are the best stocks to buy now in an uncertain market? 
Via The Motley Fool
Top 5 Health Care Stocks That Are Set To Fly In Q2
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
STAAR Surgical Revises Strategy Amid Slow U.S. Adoption, Analyst Adjusts Rating to Market Perform
William Blair downgraded Staar Surgical Co (NASDAQ: STAA) from Outperform to Market Perform, noting a lack 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
Via Benzinga
2 Stocks With Unstoppable Growth Potential for the Next Decade
There isn't much holding either of these companies back from expanding more. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023
Via Benzinga
Analyst Reiterates This Ophthalmology Device Stock On Steep But Attractive Risk/Reward
Needham analyst expects the U.S. ICL market of more than $2.4 billion, despite some investors considering the market to be niche, with STAAR Surgical Company (NASDAQ: STAA) becoming a major player in... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.